Intranasal delivery of RIG-I agonist drives pulmonary myeloid cell activation in mice
Viral respiratory infections cause substantial health and economic burden. There is a pressing demand for efficacious vaccination strategies and, therefore, a need for a better understanding of the mechanisms of action of novel potential adjuvants. Here we investigated the effect of a synthetic RIG-...
| Główni autorzy: | , , , , , |
|---|---|
| Kolejni autorzy: | |
| Format: | Journal Article |
| Język: | English |
| Wydane: |
2022
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://hdl.handle.net/10356/161476 |